Becker's Healthcare December 7, 2022
Patsy Newitt

Case numbers have long recovered since the onset of the COVID-19 pandemic, but ASC leaders are still struggling with supply costs as they compete for contracts with the deep pockets of hospitals and health systems. 

“The available and changing dynamics in the workforce and supply chain continues to create challenges and I foresee that to continue into the near future,” Todd Currier, administrator of Bend (Ore.) Surgery Center, told Becker’s. 

Supply costs, which were already burdening ASCs, are skyrocketing amid delays and inflation. Supply costs make up a median 28 percent of an ASC’s revenue, according to Avanza’s 2022 “Key ASC Benchmarks and Industry Figures” report, and the average ASC spends about $2.9 million on drugs and other medical supplies.


Today's Sponsors


Today's Sponsor

Health Edge

Topics: ASC, Healthcare System, Provider, Public Health / COVID
Meet the CEOs of 5 ASC chains
ASC market expected to reach $150.6B by 2033, report says
Orthopedic ASC raises costs $10M, pushes construction timeline
5 new ASCs in January
Some CFOs to invest less in ASCs: report

Share This Article